Clinical research software firm Clinipace has appointed David Levin as VP Marketing, responsible for product marketing and management, corporate communications, and customer experience.
Levin previously served in a number of positions in the healthcare industry, most recently as VP at MEDSEEK and etrials. Prior to this, he was VP of Marketing at MercuryMD, which was acquired by the Thomson Corporation in 2006.
CEO Jeff Williams commented: ‘David brings us a 15-year record of successfully positioning companies and their products within the healthcare industry, and delivering positive client satisfaction outcomes. We are entering an exciting time and David will spearhead efforts to bring our message to more life sciences customers.’
Clinipace offers a single, integrated data capture and study management platform for post-approval research conducted by biopharmaceutical and medical device companies, Clinical Research Organizations (CROs) and Academic Medical Centers (AMCs). Based in the Research Triangle Park (RTP) in North Carolina, the firm is online at www.clinipace.com .